We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00192621
Recruitment Status : Completed
First Posted : September 19, 2005
Last Update Posted : April 12, 2012
Sponsor:
Collaborators:
St Vincent's Hospital, Sydney
National Heart, Lung, and Blood Institute (NHLBI)
Garvan Institute of Medical Research
Prince of Wales Hospital, Sydney
Information provided by (Responsible Party):
Kirby Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : December 2006
  Study Completion Date : December 2006